|
|
|
Home *
Links - Lose Weight *
Be Our Link Partner *
Email Us |
Info For Xenadrine Rfa1
Xenadrine RFA-1 from Cytodyne Technologies is ranked as one of the most effective physique enhancement products on the market. Xenadrine is a potent thermogenic compound that has been Clinically tested and proven effective in promoting fat loss. Daly PA, et al. International Journal of Obesity 17 Supplement 1:s73-s78, has shown that this formula increased the rate of fat loss by up to 300%. Xenadrine's formula is highly synergist and helps boost metabolism, prevent loss of lean muscle tissue, suppress appetite and increase the burning of stored fat. Xenadrine is also a potent workout/energy enhancer that can enhance performance and increase endurance. Xenadrine RFA-1 from Cytodyne Technologies A new potent fat-burner containing the herbal form of ephedrine-caffeine-aspirin stack with the addition of the herbal form of another stimulant, synephrine. Suggested use as a dietary supplement: Take 2 capsules before breakfast or morning exercise session, and 2 more capsules at mid-afternoon. Do not exceed recommended dosage. Individuals weighing less than 150lbs. may wish to begin by using half the recommended dosage for the first week. Warnings: If you are pregnant or nursing, or you are at risk or are being treated for high blood pressure, heart, liver thyroid or psychiatric disease, diabetes pernicious anemia, nervousness, headache, anxiety, depression, seizure disorder, stroke or difficulty in urination due to prostate enlargement. Consult your health care professional before use if you are taking mao inhibitor or any other prescription drug. Discontinue use and consult your health care professional if dizziness sleeplessness, tremors, nervousness, headache, heart palpitations or tingling sensations occur. Not intended for use for persons under the age of 18. Info For Xenadrine Rfa1 Essential health and weight loss diet information that teaches you the truth about fast weight loss programs that promise quick weight loss. ... |
|
